Plant Comparison
Andrographis vs Turmeric
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Andrographis and Turmeric: they share 6 indicated uses (arthritis / joint pain, cancer (anticancer research), infection (general), …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Andrographis | Turmeric | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 3/10 | Stronger for Andrographis |
| Cancer (anticancer research) | 2/10 | 1/10 | Comparable evidence |
| Infection (general) | 8/10 | 3/10 | Stronger for Andrographis |
| Inflammation (general) | 5/10 | 3/10 | Stronger for Andrographis |
| Skin irritation | 5/10 | 3/10 | Stronger for Andrographis |
| Wounds | 5/10 | 3/10 | Stronger for Andrographis |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The principal yellow-orange pigments and best-studied bioactive compounds, responsible for most of turmeric's anti-inflammatory and antioxidant activity; oral bioavailability is low unless combined with piperine or a lipid carrier.
Aromatic sesquiterpenes (including turmerone) contributing to fragrance and additional bioactivity.
Pharmacological Actions
Andrographolide, the principal diterpene lactone of Andrographis paniculata, suppresses proliferation and induces apoptosis across breast, lung, colon, cervical, hepatic and haematological cancers via NF-kappaB and PI3K/Akt inhibition (preclinical).
Traditional & Indicated Uses
inferred from anti-inflammatory action
Andrographolide (from Andrographis paniculata) acts as a chemopreventive and antitumour agent against breast, lung, colorectal, cervical, prostate and hepatocellular cancers and leukaemia, inducing apoptosis and inhibiting NF-kappaB and PI3K/AKT signalling (preclinical).
Symptomatic relief of the common cold and acute upper respiratory tract infection (reduces symptom severity and duration)
Immunostimulant / immune support
Symptomatic relief of the common cold and acute upper respiratory tract infection (reduces symptom severity and duration)
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from gastroprotective action
inferred from antidiabetic action
inferred from anticancer action
inferred from gastroprotective action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Avoid in pregnancy and when trying to conceive: high doses have shown reproductive toxicity in animals and the herb has a traditional reputation as an abortifacient.
High doses have caused nephrotoxicity and reproductive toxicity in studies; use standardized products at recommended doses and avoid prolonged high-dose use.
Generally very safe in culinary quantities. High-dose curcumin supplements may cause gastrointestinal upset. May interact with anticoagulants (warfarin), antidiabetic drugs, and acid-suppressing medications. Avoid very high doses during pregnancy and breastfeeding. Rarely causes allergic reactions.
Duke (2002) rates turmeric as +++ with clinical evidence (score 2) for anti-inflammatory activity, consistent with Commission E and WHO approvals. Curcumin is the primary bioactive compound with well-documented anti-inflammatory, antioxidant, anti-aggregant, and hepatoprotective effects. Duke notes Commission E approval for dyspeptic complaints. Dose: 1.5–3 g dried rhizome powder daily. A major pharmacological consideration is bioavailability: curcumin alone has low absorption, but combining with piperine (black pepper) increases bioavailability by up to 2000%. Contraindicated in bile duct obstruction; use with caution in gallstones and during pregnancy at medicinal doses (Duke, 2002).
External Ids
Botanical Description
Erect, branching annual herb with a slender, quadrangular (square-sectioned), dark green stem. The leaves are opposite, lance-shaped and glabrous, with a short stalk. Small, two-lipped, white flowers with purple-pink markings are borne in loose, spreading axillary and terminal racemes. The whole plant, and especially the leaves, is intensely and characteristically bitter.[11]
Rhizomatous perennial herb with large, broad, lance-shaped leaves arising directly from the underground rhizome in a clump. Pale yellow flowers are borne in a dense spike partly hidden among pale green to pink upper bracts. The branching, knobbly rhizome has a bright orange-yellow interior, the source of turmeric spice and dye.[1]
Habitat
Native to India and Sri Lanka and widely distributed through South and Southeast Asia, growing wild in plains, hillsides, roadsides and cultivated fields; also grown commercially as a medicinal crop.[11]
Native to South Asia (India) and Southeast Asia; cultivated extensively in warm, humid tropical climates on well-drained, fertile soils.
Harvesting
The aerial parts (leaves and tender stems) are cut just before or at the onset of flowering, when andrographolide content is typically highest, and dried in shade to preserve the bitter diterpenoid lactones.[11]
The rhizomes are dug at the end of the growing season, typically 8-10 months after planting, when the leaves have died back; they are cleaned, boiled or steamed, then dried and often ground into the familiar yellow powder.
Traditional Uses
Andrographis, the 'king of bitters', is a cornerstone bitter tonic of Ayurvedic and traditional Chinese medicine (Chuan xin lian), used for fevers, colds, sore throat, infections and liver complaints. This traditional reputation for treating the common cold and upper respiratory infections is now supported by clinical trials of standardised extracts.[10, 12]
Turmeric rhizome is a cornerstone spice and medicine of Ayurvedic and traditional Chinese medicine, used for millennia as an anti-inflammatory, digestive and wound-healing remedy and valued as a golden dye; its curcuminoid-rich rhizome is now among the most extensively researched botanicals for inflammatory and joint conditions, directly building on this traditional reputation.[1, 13]
Preparations
Dried aerial parts infused or lightly decocted in hot water as a very bitter traditional fever and cold remedy.
Rhizome extract standardised to curcuminoid content, often combined with piperine (black pepper extract) to improve absorption, taken as capsules; the form used in most clinical arthritis and inflammation studies.
Dosage
Clinical trials for upper respiratory infection commonly use extracts standardised to around 60-120 mg andrographolide daily, in divided doses, for up to 5-7 days. Educational reference only, not a prescription.
The WHO monograph on Herba Andrographidis gives, by indication - for the common cold, 1.5-3.0 g of the powdered crude drug three times daily, after meals and at bedtime; for pyrexia, a decoction from 3 g of the crude drug twice daily; for diarrhoea, a decoction from 3-9 g as a single dose as needed, or two 500 mg tablets four times daily. Note that the EMA HMPC assessed this herb and issued a public statement rather than a monograph, so there is no EU posology. Educational reference only, not a prescription.
Clinical trials in arthritis commonly use around 1000-1500 mg of curcumin (or curcuminoid-standardised extract) daily, in divided doses, often combined with piperine. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
References & Sources
- Okonogi, R. and others (2023) 'Efficacy of Andrographis paniculata spray in acute pharyngitis: A randomized controlled trial', Drug Discoveries & Therapeutics, 17(5), pp. 315-321. doi:10.5582/ddt.2023.01053 Randomized trial
https://doi.org/10.5582/ddt.2023.01053 - Hossain, S., Urbi, Z., Karuniawati, H., Mohiuddin, R.B. and others (2018) 'Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide', Critical Reviews in Food Science and Nutrition, 61(10), pp. 1635-1652. doi:10.1080/10408398.2018.1501657 Meta-analysis / review
https://doi.org/10.1080/10408398.2018.1501657 - Worakunphanich, W. and others (2021) 'Andrographis paniculata Formulations: Impact on Diterpene Lactone Oral Bioavailability', European Journal of Drug Metabolism and Pharmacokinetics, 46(5), pp. 565-581. doi:10.1007/s13318-021-00736-7 Meta-analysis / review
https://doi.org/10.1007/s13318-021-00736-7 - Worakunphanich, W., Thavorncharoensap, M., Youngkong, S., Thakkinstian, A. and Chaikledkaew, U (2021) 'Safety of Andrographis paniculata: A systematic review and meta-analysis', Pharmacoepidemiology and Drug Safety, 30(6), pp. 727-739. doi:10.1002/pds.5190 Meta-analysis / review
https://doi.org/10.1002/pds.5190 - Kumar, S., Singh, B. and Bajpai, V (2021) 'Andrographis paniculata (Burm.f.) Nees and its major constituent andrographolide as potential antiviral agents', Journal of Ethnopharmacology, 274, pp. 113954. doi:10.1016/j.jep.2021.113954 Meta-analysis / review
https://doi.org/10.1016/j.jep.2021.113954 - Barbosa, F.L. and others (2021) 'Andrographis paniculata (Burm. f.) Wall. ex Nees: An Updated Review of Phytochemistry, Antimicrobial Pharmacology, and Clinical Safety and Efficacy', Life, 11(4), pp. 348. doi:10.3390/life11040348 Meta-analysis / review
https://doi.org/10.3390/life11040348 - Singh, P. and others (2022) 'Andrographis paniculata mitigates first-line anti-tubercular drugs-induced nephrotoxicity in Wistar rats', Biomarkers, 27(4), pp. 385-394. doi:10.1080/1354750X.2022.2043444 Preclinical
https://doi.org/10.1080/1354750X.2022.2043444 - Coon, J.T. and Ernst, E (2004) 'Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials', Journal of Clinical Pharmacy and Therapeutics, 29(1), pp. 37-45. doi:10.1046/j.1365-2710.2003.00534.x Meta-analysis / review
https://doi.org/10.1046/j.1365-2710.2003.00534.x - Rondee, N. and others (2023) 'The Effects of Andrographis paniculata (Burm.F.) Wall. Ex Nees and Andrographolide on Neuroinflammation in the Treatment of Neurodegenerative Diseases', Nutrients, 15(15), pp. 3428. doi:10.3390/nu15153428 Meta-analysis / review
https://doi.org/10.3390/nu15153428 - Zeng, B., Wei, A., Zhou, Q., Yuan, M., Lei, K., Liu, Y., Song, J., Guo, L. and Ye, Q (2021) 'Andrographolide: A review of its pharmacology, pharmacokinetics, toxicity and clinical trials and pharmaceutical researches', Phytotherapy Research. doi:10.1002/ptr.7324 Randomized trial
https://doi.org/10.1002/ptr.7324 - Gonde, D.P., Bhole, B.K. and Kakad, K.S (2023) 'Andrographolide, diterpenoid constituent of Andrographis paniculata: Review on botany, phytochemistry, molecular docking analysis, and pharmacology', Annales Pharmaceutiques Francaises. doi:10.1016/j.pharma.2023.10.001 Preclinical
https://doi.org/10.1016/j.pharma.2023.10.001 - Hu, X.Y., Wu, R.H., Logue, M., Blondel, C., Lai, L.Y.W., Stuart, B., Flower, A., Fei, Y.T., Moore, M., Shepherd, J., Liu, J.P. and Lewith, G (2017) 'Andrographis paniculata (Chuan Xin Lian) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis', PLoS ONE. doi:10.1371/journal.pone.0181780 Meta-analysis / review
https://doi.org/10.1371/journal.pone.0181780 - World Health Organization (2002) 'Herba Andrographidis'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Tundis, R. and Patra, J.K. and Bonesi, M. and Das, S. and Nath, R. and Das Talukdar, A. and Das, G. and Loizzo, M.R (2023) 'Anti-Cancer Agent: The Labdane Diterpenoid-Andrographolide', Plants, 12(10), pp. 1969. doi:10.3390/plants12101969 Preclinical
https://doi.org/10.3390/plants12101969 - Mishra, S.K. and Tripathi, S. and Shukla, A. and Oh, S.H. and Kim, H.M (2015) 'Andrographolide and analogues in cancer prevention', Frontiers in Bioscience (Elite Edition), 7(2), pp. 255-266. doi:10.2741/E732 Preclinical
https://doi.org/10.2741/E732 - Paul, S. and Roy, D. and Pati, S. and Sa, G (2021) 'The Adroitness of Andrographolide as a Natural Weapon Against Colorectal Cancer', Frontiers in Pharmacology, 12, pp. 731492. doi:10.3389/fphar.2021.731492 Preclinical
https://doi.org/10.3389/fphar.2021.731492 - Memorial Sloan Kettering Cancer Center (n.d.) 'Andrographis (About Herbs)'. Available at: https://www.mskcc.org/cancer-care/integrative-medicine/herbs/andrographis Traditional / reference
https://www.mskcc.org/cancer-care/integrative-medicine/herbs/andrographis
- Zeng, L., Yang, T., Yang, K., Yu, G. et al (2022) 'Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Frontiers in Immunology, 13, pp. 891822. doi:10.3389/fimmu.2022.891822 Meta-analysis / review
https://doi.org/10.3389/fimmu.2022.891822 - Zeng, L., Yu, G., Hao, W., Yang, K. and Chen, H (2021) 'The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis', Bioscience Reports, 41(6), pp. BSR20210817. doi:10.1042/BSR20210817 Meta-analysis / review
https://doi.org/10.1042/BSR20210817 - Marton, L.T., Pescinini-E-Salzedas, L.M., Camargo, M.E.C., Barbalho, S.M. et al (2021) 'The Effects of Curcumin on Diabetes Mellitus: A Systematic Review', Frontiers in Endocrinology, 12, pp. 669448. doi:10.3389/fendo.2021.669448 Meta-analysis / review
https://doi.org/10.3389/fendo.2021.669448 - Kocaadam, B. and Sanlier, N (2017) 'Curcumin, an active component of turmeric (Curcuma longa), and its effects on health', Critical Reviews in Food Science and Nutrition, 57(13), pp. 2889-2895. doi:10.1080/10408398.2015.1077195 Meta-analysis / review
https://doi.org/10.1080/10408398.2015.1077195 - Vaughn, A.R., Branum, A. and Sivamani, R.K (2016) 'Effects of turmeric (Curcuma longa) on skin health: a systematic review of the clinical evidence', Phytotherapy Research, 30(8), pp. 1243-1264. doi:10.1002/ptr.5640 Meta-analysis / review
https://doi.org/10.1002/ptr.5640 - Soleimani, V., Sahebkar, A. and Hosseinzadeh, H (2018) 'Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: review', Phytotherapy Research, 32(6), pp. 985-995. doi:10.1002/ptr.6054 Meta-analysis / review
https://doi.org/10.1002/ptr.6054 - Zeng, L., Yang, T., Yang, K., Yu, G., Li, J., Xiang, W. and Chen, H (2022) 'Curcumin and Curcuma longa extract in the treatment of 10 types of autoimmune diseases: a systematic review and meta-analysis of 31 randomized controlled trials', Frontiers in Immunology, 13, pp. 896476. doi:10.3389/fimmu.2022.896476 Meta-analysis / review
https://doi.org/10.3389/fimmu.2022.896476 - Razavi, B.M., Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2021) 'A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents', Phytotherapy Research, 35(12), pp. 6489-6513. doi:10.1002/ptr.7224 Meta-analysis / review
https://doi.org/10.1002/ptr.7224 - Memarzia, A., Khazdair, M.R., Behrouz, S., Gholamnezhad, Z., Jafarnezhad, M., Saadat, S. and Boskabady, M.H (2021) 'Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review', BioFactors, 47(3), pp. 311-350. doi:10.1002/biof.1716 Meta-analysis / review
https://doi.org/10.1002/biof.1716 - Jurenka, J.S (2009) 'Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research', Alternative Medicine Review, 14(2), pp. 141-153. Meta-analysis / review
https://scholar.google.com/scholar?q=Anti-inflammatory%20properties%20of%20curcumin%2C%20a%20major%20constituent%20of%20Curcuma%20longa%3A%20a%20review%20of%20preclinical%20and%20clinical%20research - Hosseini, A. and Hosseinzadeh, H (2018) 'Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: a review', Biomedicine & Pharmacotherapy, 99, pp. 411-421. doi:10.1016/j.biopha.2018.01.072 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2018.01.072 - Araujo, C.C. and Leon, L.L (2001) 'Biological activities of Curcuma longa L', Memorias do Instituto Oswaldo Cruz, 96(5), pp. 723-728. doi:10.1590/s0074-02762001000500026 Meta-analysis / review
https://doi.org/10.1590/s0074-02762001000500026 - Aggarwal, B.B. and Harikumar, K.B (2009) 'Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases', 41(1), pp. 40--59. doi:10.1016/j.biocel.2008.06.010 Traditional / reference
https://doi.org/10.1016/j.biocel.2008.06.010 - Shoba, G. et al (1998) 'Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers', 64(4), pp. 353--356. doi:10.1055/s-2006-957450 Clinical study
https://doi.org/10.1055/s-2006-957450 - WHO (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Liu, A.C., Zhao, L.X. and Lou, H.X (2013) 'Curcumin alters the pharmacokinetics of warfarin and clopidogrel in Wistar rats but has no effect on anticoagulation or antiplatelet aggregation', Planta Medica, 79(11), pp. 971-977. doi:10.1055/s-0032-1328652 Preclinical
https://doi.org/10.1055/s-0032-1328652 - Tian, J., Feng, B. and Tian, Z (2022) 'The Effect of Curcumin on Lipid Profile and Glycemic Status of Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis', Evidence-Based Complementary and Alternative Medicine, 2022, pp. 8278744. doi:10.1155/2022/8278744 Meta-analysis / review
https://doi.org/10.1155/2022/8278744 - Willcox, M.L., Elugbaju, C., Al-Anbaki, M., Lown, M. and Graz, B (2021) 'Effectiveness of Medicinal Plants for Glycaemic Control in Type 2 Diabetes: An Overview of Meta-Analyses of Clinical Trials', Frontiers in Pharmacology, 12, pp. 777561. doi:10.3389/fphar.2021.777561 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.777561 - Altobelli, E., Angeletti, P.M., Marziliano, C., Mastrodomenico, M., Giuliani, A.R. and Petrocelli, R (2021) 'Potential therapeutic effects of curcumin on glycemic and lipid profile in uncomplicated type 2 diabetes: a meta-analysis of randomized controlled trials', Nutrients, 13(2), pp. 404. doi:10.3390/nu13020404 Meta-analysis / review
https://doi.org/10.3390/nu13020404
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.